Genome Abnormalities Precede Prostate Cancer and Predict Clinical Relapse
نویسندگان
چکیده
منابع مشابه
Using biomarkers to predict prostate cancer biochemical relapse
The early detection of prostate cancer with prostatespecific antigen (PSA) testing allows many patients the option of radical treatment with curative intent. However, up to 30% of patients undergoing radical prostatectomy for clinically localized disease will experience biochemical relapse. In some cases, biochemical relapse represents micro-metastatic disease, undetectable before surgery and a...
متن کاملPlasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer
Liquid biopsies, examinations of tumor components in body fluids, have shown promise for predicting clinical outcomes. To evaluate tumor-associated genomic and genetic variations in plasma cell-free DNA (cfDNA) and their associations with treatment response and overall survival, we applied whole genome and targeted sequencing to examine the plasma cfDNAs derived from 20 patients with advanced p...
متن کاملClinical and Pathological Features of Iraqi Patients with Prostate Cancer
Background: The clinical pathological features were detected by measuring the prostatic acid phosphatase (PAP) activity according to the stages and grades of prostate cancer. We also explored the relationship between the disease and age with family history among the patients. Methods: Data were collected from direct interview and from the patient’s records. Blood samples that collected before ...
متن کاملVEGFR1 and NRP1 endothelial expressions predict distant relapse after radical prostatectomy in clinically localized prostate cancer.
Prostate cancer can usually be treated at a clinically localized stage by radical prostatectomy. Unfortunately, within 10 years following surgery, 30% of patients experience local or distant relapse. Few data exist on the association of markers of angiogenesis and distant relapse after radical prostatectomy. By immunohistochemistry in tissue microarray, we compared the expression pattern of hyp...
متن کاملmiRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression.
Prostate cancer is the leading cancer diagnosed and the second most common cause of cancer related death in the western world. For prognostic monitoring after prostatectomy, recurrent increase of prostate-specific antigen (PSA), the so-called PSA or biochemical relapse remains the leading biomarker. There is currently no biomarker that can accurately predict the risk of relapse at the time of s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The American Journal of Pathology
سال: 2012
ISSN: 0002-9440
DOI: 10.1016/j.ajpath.2012.03.008